Personalized Treatment Plans
482 articles
A Second Opinion Felt Right
Bonnie Dahl considered treatment for stage I pancreatic cancer near home but felt a second opinion and a bigger cancer center were important.
A Fighting Spirit
Resilience best describes Dr. Errol D. Toulon, Jr., a long-term survivor of lymphoma, pancreatic cancer, and a heart emergency.
Lots and Lots of Research Leads to a Better Outcome
Dan Grunfeld put his experience as a chemist to good use as he researched pancreatic cancer treatments to find a clinical trial.
Always Insist On More
Dave Paffenroth’s wife Wendy was an extraordinary caregiver, coordinating treatments and family support during pancreatic cancer treatment.
A Life-Changing Diagnosis: My PNET
Lalenya Robertson’s stomach problems were a mystery until she mentioned family members’ pancreatic cancer and pancreatitis. Diagnosis: PNET.
Sometimes Things Get Worse Before They Get Better
Matthew Rosenblum thought his time was limited after a pancreatic cancer diagnosis at age 32, but he’s a BRCA2 carrier, which opened treatment options.
Genetic Testing Changed My Chemo Protocol
Greg Jacobson’s family has an extensive history of cancer. After a pancreatic cancer diagnosis, genetic testing found the mutation for Lynch syndrome.
Don’t Throw In the Towel
Ashley Coker was dealt a double blow–pancreatic cancer and not qualifying for surgery. She did her research and ended up having a pancreatectomy.
No Symptoms Whatsoever
Judd Levy had no symptoms when diagnosed with stage IV pancreatic cancer. He responded so well to treatment he was able to have a Whipple.
No Time for Self-Pity
When David Smith started losing weight after a diabetes diagnosis, his daughter-in-law was concerned because she had seen this before.
Three Ways to Be your Own Best Health Advocate
Leslie Michelson recommends putting together a health care team of friends, advocates and physicians for the best possible care after a cancer diagnosis.
Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
The First Line of Defense against Pancreatic Cancer
Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.
Combination Delivers a Dual Punch to Pancreatic Cell Growth
Dr. Conan Kinsey outlines a clinical trial that has moved quickly from the lab to phase I, with a dual approach to delivering pancreatic cancer treatment.
Using Tumor Tissue Samples to Break Down Assumptions About Pancreatic Cancer
Dr. Christine Iacobuzio-Donahue uses tumor tissue samples to study how pancreatic cancer tumors develop, so she can find ways to stop the disease.